Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Net Margin (2016 - 2026)

Phibro Animal Health has reported Net Margin over the past 14 years, most recently at 7.34% for Q4 2025.

  • For Q4 2025, Net Margin rose 631.0% year-over-year to 7.34%; the TTM value through Dec 2025 reached 6.29%, up 563.0%, while the annual FY2025 figure was 3.72%, 466.0% up from the prior year.
  • Net Margin for Q4 2025 was 7.34% at Phibro Animal Health, up from 7.29% in the prior quarter.
  • Over five years, Net Margin peaked at 7.5% in Q4 2021 and troughed at 4.12% in Q2 2024.
  • A 5-year average of 2.98% and a median of 3.0% in 2022 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: crashed -512bps in 2023 and later surged 866bps in 2025.
  • Year by year, Net Margin stood at 7.5% in 2021, then plummeted by -61bps to 2.95% in 2022, then plummeted by -83bps to 0.51% in 2023, then skyrocketed by 102bps to 1.03% in 2024, then surged by 613bps to 7.34% in 2025.
  • Business Quant data shows Net Margin for PAHC at 7.34% in Q4 2025, 7.29% in Q3 2025, and 4.55% in Q2 2025.